XLV vs IXJ
YTDYear to date
XLV wins+4.4 pts
Past year
XLV wins+4.9 pts
Fee
XLV winslower fee
Yield
XLV wins+0.1 pts
AUM
XLV10.3× more
4–0XLV wins
XLV and IXJ · year-to-date · as of Nov 5, 2026 · AUM not scored
IXJ vs S&P 500
3M$115.53 · +3.2% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3M ▼YTD1Y3Y5YMAX
Total return+3.2%+14.0%+14.1%+19.7%+28.6%+53.0%+43.9%+480.6%
Peer average+2.7%+8.5%+8.9%+24.4%+33.4%+84.3%+34.0%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%+831.3%
iShares IXJ and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
IXJ’s Holdings
TodayLLYEli Lilly11.6%JNJ6.6%ABBV5.2%UNH4.1%MRK4.0%ROP.SW3.8%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%ABT2.1%PFE1.9%ISRG1.8%DHR1.6%VRTX1.5%NOVO-B.CO1.5%BMY1.4%MDT1.4%CVS1.3%87 more
LLYEli Lilly11.6%JNJ6.6%ABBV5.2%UNH4.1%MRK4.0%ROP.SW3.8%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%97 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - DevicesMedical - Healthcare PlansBiotechnologyMedical - InstrumentsOther
iShares IXJ · 109 holdings · tile size = share of the fund · as of Nov 4, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.3% | +24.0% | +24.0% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +23.3% | +23.3% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +30.6% | +30.6% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +23.7% | +23.7% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +23.4% | +23.4% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +71.5% | +71.5% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +29.8% | +29.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +27.1% | +27.1% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +26.0% | +26.0% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.6% | +36.8% | +36.8% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +20.4% | +20.4% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +26.8% | +26.8% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +26.9% | +26.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +38.2% | +38.2% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
IXJ Payouts by Year
13YLatest payout, Jun 2026
$0.85
a share · twice a year
1.2% yield
1.2% yield
13 years added up
$13.64 a share
$13.64 a share
iShares IXJ · per-share distributions by ex-date · 2014–2026
IXJ’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.3% | +3.1% | +24.0% | +33.5% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +3.1% | +23.3% | +32.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +2.7% | +30.6% | +45.4% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +3.3% | +23.7% | +32.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFThis fund | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | IHI | iShares U.S. Medical Devices ETFReadVersus | 0.37% | 0.4% | +6.7% | −2.7% | −0.4% | $4.1B |
#21 of 33 this year · #19 cheapest of 39 · sorted by assetsOpen the Sectors table →
IXJ and its peer group · total return · as of Nov 5, 2026
Cards for This View
IXJ’s Top 10 Holdings
Today47.7%of IXJ sits in these 10
7NOVN.SNovartis Ag3.33%
iShares IXJ · weight in the fund · as of Nov 4, 2026
IXJ’s Holdings
TodayLLYEli Lilly11.6%JNJ6.6%ABBV5.2%UNH4.1%MRK4.0%ROP.SW3.8%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%ABT2.1%PFE1.9%ISRG1.8%DHR1.6%VRTX1.5%NOVO-B.CO1.5%BMY1.4%MDT1.4%CVS1.3%87 more
LLYEli Lilly11.6%JNJ6.6%ABBV5.2%UNH4.1%MRK4.0%ROP.SW3.8%NOVN.SW3.3%AZN.L3.2%TMO2.9%AMGN2.8%GILD2.4%97 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - DevicesMedical - Healthcare PlansBiotechnologyMedical - InstrumentsOther
iShares IXJ · 109 holdings · tile size = share of the fund · as of Nov 4, 2026
IXJ vs Peer Average
YTDIXJAvsBPeer average
1D+3.2%+2.7%
1M+14.0%+8.5%
3M+14.1%+8.9%
YTD+19.7%+24.4%
1Y+28.6%+33.4%
3Y+53.0%+84.3%
5Y+43.9%+34.0%
4–3IXJ wins
38 Health care peers · each row scaled to its leader